Connect with us

Hi, what are you looking for?

Health News

Can HIV be actually prevented in high risk populations will pill?

Since the 1990s, there have been a lot of drugs fighting against HIV which have actually prevented the death of those affected by this disease.

Research is extensively on now to determine whether these drugs could actually work with prevention of this deadly disease in areas of high risk.
Studies and clinical trials are being conducted to find out if taking these drugs on a preventive basis will actually help protect those who are not yet infected by this virus.
Any concrete evidence from this could be another step in the efforts to fight this disease which has already claimed 25 million lives so far and has affected at least 32 million since the year 1980.
According to Anthony S. Fauci, one of the top fighters in the US against this disease and the director, National Institutes of Health, Bethsda, Maryland’s National Institute of Allergy and Anfectious Diseases, this approach is very optimistic and he is very enthusiastic about it.
Fauci said that efforts are on for more than a decade to find a vaccine for the HIV virus which has been deceptively frustrating scientists all over the world. He also said that any idea which promises a cure or prevention for this is welcome. He was speaking to the Deutsche Presse-Agentur dpa this week.
Though there was no conclusive evidence yet, there are indications of the possibility of prevention with medications based on results from animal testing. He hopes there will be some results by next year.
Two pills, one containing Emtricitabine and the other containing Tenofovir are being tested for preventive treatment of the HIV virus.

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...